Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder.
- Authors
- Berk, M; Dodd, S; Kauer-Sant'anna, M; Malhi, G S; Bourin, M; Kapczinski, F; Norman, T
- Year
- 2007
- Journal
- Acta psychiatrica Scandinavica. Supplementum
- PMID
- 17688462
- DOI
- 10.1111/j.1600-0447.2007.01058.x
OBJECTIVE: Rational therapeutic development in bipolar is hampered by a lack of pathophysiological model. However, there is a wealth of converging data on the role of dopamine in bipolar disorder. This paper therefore examines the possibility of a dopamine hypothesis for bipolar disorder. METHOD: A literature search was conducted using standard search engines Embase, PyschLIT, PubMed and MEDLINE. In addition, papers and book chapters known to the authors were retrieved and examined for further relevant articles. RESULTS: Collectively, in excess of 100 articles were reviewed from which approximately 75% were relevant to the focus of this paper. CONCLUSION: Pharmacological models suggest a role of increased dopaminergic drive in mania and the converse in depression. In Parkinson's disease, administration of high-dose dopamine precursors can produce a 'maniform' picture, which switches into a depressive analogue on withdrawal. It is possible that in bipolar disorder there is a cyclical process, where increased dopaminergic transmission in mania leads to a secondary down regulation of dopaminergic receptor sensitivity over time. This may lead to a period of decreased dopaminergic transmission, corresponding with the depressive phase, and the repetition of the cycle. This model, if verified, may have implications for rational drug development.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Integrative transcriptomic meta-analysis reveals immune, synaptic, and non-coding RNA dysregulation in bipolar disorder across brain and blood. | Panina A et al. | β | 2026 | β |
| A Common Cause of ADHD and Bipolar Disorder (BD). | Avinoam R et al. | β | 2025 | β |
| Are There Connections between the Neuroendocrine and Dopamine Systems in Bipolar Disorder? | Trouillas J et al. | β | 2025 | β |
| Comprehensive Review on Association of Bipolar Disorder and Substance Abuse: Dual Diagnosis and Treatment Approaches. | Bonner-Reid FT et al. | β | 2025 | β |
| Ferroptosis as a potential molecular mechanism of bipolar disorder. | Yehia A et al. | β | 2025 | β |
| Linking Mitochondrial Dysfunction, Neurotransmitter, and Neural Network Abnormalities and Mania: Elucidating Neurobiological Mechanisms of the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder. | Freyberg Z et al. | β | 2025 | β |
| Lithium as a disease-modifying drug for bipolar disorder. | Post RM et al. | β | 2025 | β |
| Long-Term Efficacy and Resting-State Functional Magnetic Resonance Imaging Changes of Deep Brain Stimulation in the Lateral Habenula Nucleus for Treatment-Resistant Bipolar Disorder. | Jiang C et al. | β | 2025 | β |
| Machine learning-based differentiation of schizophrenia and bipolar disorder using multiscale fuzzy entropy and relative power from resting-state EEG. | Hwang HH et al. | β | 2025 | β |
| Neurotransmitters in Neural Circuits and Neurological Diseases. | Gholami A et al. | β | 2025 | β |
| Preliminary exploration of potential biomarkers for heart failure and bipolar disorder: an exploratory study based on bioinformatics. | Zhang W et al. | β | 2025 | β |
| Reward Processing in Mood Disorders and Schizophrenia: A Neurodevelopmental Framework. | Nusslock R et al. | β | 2025 | β |
| Risk of subsequent Parkinson's disease among patients with bipolar disorder or major depression: A nationwide longitudinal study in Taiwan. | Huang MH et al. | β | 2025 | β |
| Trace amine-associated receptor 1 (TAAR1) activation reduced mania-relevant hyperexploration and risky decision-making in dopamine transporter knockdown mice. | Munir TY et al. | β | 2025 | β |
| Anti-manic effect of deep brain stimulation of the ventral tegmental area in an animal model of mania induced by methamphetamine. | Varela RB et al. | β | 2024 | β |
| Associations between dietary habits and bipolar disorder: a diet-wide mendelian randomization study. | Li J et al. | β | 2024 | β |
| Deletion of histamine H2 receptor in VTA dopaminergic neurons of mice induces behavior reminiscent of mania. | Ma S et al. | β | 2024 | β |
| Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force. | Miskowiak KW et al. | β | 2024 | β |
| Intracellular effects of lithium in aging neurons. | Godoy JA et al. | β | 2024 | β |
| L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review. | Wang W et al. | β | 2024 | β |
| Pharmacological Mechanism of Herbal Interventions for Bipolar Disorder. | Singh A et al. | β | 2024 | β |
| The emerging neuroimmune hypothesis of bipolar disorder: An updated overview of neuroimmune and microglial findings. | Chaves-Filho A et al. | β | 2024 | β |
| The Pathophysiological Underpinnings of Gamma-Band Alterations in Psychiatric Disorders. | Palmisano A et al. | β | 2024 | β |
| Unraveling the role of the renin-angiotensin system in severe mental illnesses: An insight into psychopathology and cognitive deficits. | de Miranda AS et al. | β | 2024 | β |
| Vitamin D3 and zinc supplements augment the antimanic efficacy of lithium and olanzapine treatments in an animal model of mania. | Huzayyin AAS et al. | β | 2024 | β |
| Abnormal features of human self-domestication in bipolar disorder. | BenΓtez-Burraco A et al. | β | 2023 | β |
| Absconding among admitted patients with bipolar affective disorder diagnosis in Uganda. | Abaatyo J et al. | β | 2023 | β |
| Amantadine in Treatment of Dysthymia-The Pilot Case Series Study. | Krzystanek M et al. | β | 2023 | β |
| Case report: Dopamine Dysregulation Syndrome, mania, and compulsive buying in a patient with Parkinson's disease. | Silva C et al. | β | 2023 | β |
| Comparative efficacy, acceptability, and tolerability of adjunctive anti-inflammatory agents on bipolar disorder: A systemic review and network meta-analysis. | Xu H et al. | β | 2023 | β |
| Effects of varenicline on the serum levels of olanzapine in male patients with Schizophrenia: a randomized controlled trial. | Deng M et al. | β | 2023 | β |
| Examining the link between impulse control disorder and antidepressant use in Parkinson's disease. | Morrow CB et al. | β | 2023 | β |
| Gait disorders in unipolar and bipolar depression. | Bogdanova D | β | 2023 | β |
| High frequency deep brain stimulation can mitigate the acute effects of cocaine administration on tonic dopamine levels in the rat nucleus accumbens. | Yuen J et al. | β | 2023 | β |
| Oxycodone-induced dopaminergic and respiratory effects are modulated by deep brain stimulation. | Yuen J et al. | β | 2023 | β |
| Pushing the Frontiers: Optogenetics for Illuminating the Neural Pathophysiology of Bipolar Disorder. | Kong L et al. | β | 2023 | β |
| A motivation model of sex addiction - Relevance to the controversy over the concept. | Toates F | β | 2022 | β |
| Association of Polymorphism within the Putative miRNA Target Site in the 3'UTR Region of the <i>DRD2</i> Gene with Neuroticism in Patients with Substance Use Disorder. | BoroΕ A et al. | β | 2022 | β |
| Biomarker potential of hsa-miR-145-5p in peripheral whole blood of manic bipolar I patients. | Tekin SS et al. | β | 2022 | β |
| Bipolar spectrum disorders in neurologic disorders. | Digiovanni A et al. | β | 2022 | β |
| Circadian rhythms as modulators of brain health during development and throughout aging. | Van Drunen R et al. | β | 2022 | β |
| Gut Microbiota - A Potential Contributor in the Pathogenesis of Bipolar Disorder. | Zhang P et al. | β | 2022 | β |
| Inhibition of glycogen synthase kinase 3 by lithium, a mechanism in search of specificity. | Chatterjee D et al. | β | 2022 | β |
| Is SARS-CoV-2 a Risk Factor of Bipolar Disorder?-A Narrative Review. | Lorkiewicz P et al. | β | 2022 | β |
| Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview. | Ochoa ELM | β | 2022 | β |
| Neurobiological and behavioral mechanisms of circadian rhythm disruption in bipolar disorder: A critical multi-disciplinary literature review and agenda for future research from the ISBD task force on chronobiology. | McCarthy MJ et al. | β | 2022 | β |
| Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers. | Lee JG et al. | β | 2022 | β |
| Risperidone Induced Hyperprolactinemia: From Basic to Clinical Studies. | Stojkovic M et al. | β | 2022 | β |
| Schizophrenia, Bipolar and Major Depressive Disorders: Overview of Clinical Features, Neurotransmitter Alterations, Pharmacological Interventions, and Impact of Oxidative Stress in the Disease Process. | Mandal PK et al. | β | 2022 | β |
| Strategies and foundations for scientific discovery in longitudinal studies of bipolar disorder. | McInnis MG et al. | β | 2022 | β |
| The effects of early life stress on impulsivity. | Sanchez EO et al. | β | 2022 | β |
| Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress-Induced Damage in Patients with Bipolar Disorder. | Madireddy S et al. | β | 2022 | β |
| Association between exposure to toxoplasmosis and major psychiatric disorders: a systematic review. | Fernandes SM et al. | β | 2021 | β |
| Biological Pathways Associated with Neuroprogression in Bipolar Disorder. | Wollenhaupt-Aguiar B et al. | β | 2021 | β |
| Bi-temporal electroconvulsive therapy efficacy in bipolar and unipolar depression: A retrospective comparison. | Gurel SC et al. | β | 2021 | β |
| Changes in striatal dopamine transporters in bipolar disorder and valproate treatment. | Hsueh YS et al. | β | 2021 | β |
| Does endogenous cholecystokinin modulate alcohol intake? | Ballaz S et al. | β | 2021 | β |
| Incidence of Parkinson's disease, dementia, cerebrovascular disease and stroke in bipolar disorder compared to other psychiatric disorders: An electronic health records network study of 66 million people. | Harrison PJ et al. | β | 2021 | β |
| Involvements of Hyperhomocysteinemia in Neurological Disorders. | Cordaro M et al. | β | 2021 | β |
| Morphological and biochemical repercussions of <i>Toxoplasma gondii</i> infection in a 3D human brain neurospheres model. | Correa Leite PE et al. | β | 2021 | β |
| Prefrontal dopamine D1 receptor manipulation influences anxiety behavior and induces neuroinflammation within the hippocampus. | Beyer DKE et al. | β | 2021 | β |
| Risky decision-making following prefrontal D1 receptor manipulation. | Beyer DKE et al. | β | 2021 | β |
| Schizophrenia and bipolar disorder are associated with opposite brain reward anticipation-associated response. | Smucny J et al. | β | 2021 | β |
| Sex Differences in Dopamine Receptors and Relevance to Neuropsychiatric Disorders. | Williams OOF et al. | β | 2021 | β |
| Using iPSC Models to Understand the Role of Estrogen in Neuron-Glia Interactions in Schizophrenia and Bipolar Disorder. | Reis de Assis D et al. | β | 2021 | β |
| Valproate reverses mania-like behaviors in mice via preferential targeting of HDAC2. | Logan RW et al. | β | 2021 | β |
| Abnormal Functional Relationship of Sensorimotor Network With Neurotransmitter-Related Nuclei via Subcortical-Cortical Loops in Manic and Depressive Phases of Bipolar Disorder. | Martino M et al. | β | 2020 | β |
| A Split Luciferase Complementation Assay for the Quantification of Ξ²-Arrestin2 Recruitment to Dopamine D<sub>2</sub>-Like Receptors. | Forster L et al. | β | 2020 | β |
| Bipolar oscillations between positive and negative mood states in a computational model of Basal Ganglia. | Balasubramani PP et al. | β | 2020 | β |
| Disorders of human consciousness in the Tri-partite synapses. | Miterauer B et al. | β | 2020 | β |
| Is being born in spring significantly associated with early-onset bipolar affective disorder? A case-control study. | Wang MQ et al. | β | 2020 | β |
| Lithium treatment impacts nucleus accumbens shape in bipolar disorder. | Vecchio D et al. | β | 2020 | β |
| Morphological and biochemical repercussions of<i>Toxoplasma gondii</i>infection in a 3D human brain neurospheres model | CorrΓͺa Leite PE et al. | β | 2020 | β |
| On the diagnostic and neurobiological origins of bipolar disorder. | Charney AW et al. | β | 2020 | β |
| P2X7 Purinergic Receptor Is Involved in the Pathophysiology of Mania: a Preclinical Study. | Gubert C et al. | β | 2020 | β |
| Possibility of a New Indication for Amantadine in the Treatment of Bipolar Depression-Case Series Study. | Krzystanek M et al. | β | 2020 | β |
| Risk of Developing Parkinson Disease in Bipolar Disorder: A Systematic Review and Meta-analysis. | Faustino PR et al. | β | 2020 | β |
| The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder. | Chaves Filho AJM et al. | β | 2020 | β |
| The predictive performance of the bipolarity index in a Dutch epidemiological sample manuscript. | Ter Meulen WG et al. | β | 2020 | β |
| ADHD with Comorbid Bipolar Disorders: A Systematic Review of Neurobiological, Clinical and Pharmacological Aspects Across the Lifespan. | Mucci F et al. | β | 2019 | β |
| A new inbred strain of Fawn-Hooded rats demonstrates mania-like behavioural and monoaminergic abnormalities. | Azechi H et al. | β | 2019 | β |
| Bipolar disorder and risk of Parkinson disease: A nationwide longitudinal study. | Huang MH et al. | β | 2019 | β |
| Cerebral Glucose Metabolism in Patients with Chronic Mental and Cognitive Sequelae after a Single Blunt Mild Traumatic Brain Injury without Visible Brain Lesions. | Komura A et al. | β | 2019 | β |
| Current Understanding of the Role of Neuronal Calcium Sensor 1 in Neurological Disorders. | Bandura J et al. | β | 2019 | β |
| Effects of lithium on inflammatory and neurotrophic factors after an immune challenge in a lisdexamfetamine animal model of mania. | Bristot G et al. | β | 2019 | β |
| Intra-individual variability in animal models of bipolar disorder. | Hawken ER et al. | β | 2019 | β |
| Methylphenidate Attenuates the Cognitive and Mood Alterations Observed in Mbnl2 Knockout Mice and Reduces Microglia Overexpression. | Ramon-Duaso C et al. | β | 2019 | β |
| Mitochondrial DNA content and oxidation in bipolar disorder and its role across brain regions. | Bodenstein DF et al. | β | 2019 | β |
| Resveratrol protects the brain against oxidative damage in a dopaminergic animal model of mania. | Menegas S et al. | β | 2019 | β |
| The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study. | Ellegaard PK et al. | β | 2019 | β |
| The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia. | Ashton MM et al. | β | 2019 | β |
| Twenty years of Lithium pharmacogenetics: A systematic review. | Pagani R et al. | β | 2019 | β |
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | Scarnati MS et al. | β | 2019 | β |
| A neuronal mechanism underlying decision-making deficits during hyperdopaminergic states. | Verharen JPH et al. | β | 2018 | β |
| Classics in Chemical Neuroscience: Risperidone. | Chopko TC et al. | β | 2018 | β |
| Evaluation of Neurotransmitter Alterations in Four Distinct Brain Regions After Rapid Eye Movement Sleep Deprivation (REMSD) Induced Mania-Like Behaviour in Swiss Albino Mice. | Siddique SA et al. | β | 2018 | β |
| Flipped Phenyl Ring Orientations of Dopamine Binding with Human and Drosophila Dopamine Transporters: Remarkable Role of Three Nonconserved Residues. | Yuan Y et al. | β | 2018 | β |
| Interspecies comparison in the COMT-mediated methylation of 3-BTD. | Xia Y et al. | β | 2018 | β |
| Motor activity patterns in acute schizophrenia and other psychotic disorders can be differentiated from bipolar mania and unipolar depression. | Krane-Gartiser K et al. | β | 2018 | β |
| Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder. | Pinto JV et al. | β | 2018 | β |
| Objective quantification of psychomotor disturbances in patients with a major depressive episode. | Terziivanova P et al. | β | 2018 | β |
| Protein Kinase C Activity and Delayed Recovery of Sleep-Wake Cycle in Mouse Model of Bipolar Disorder. | Moon E et al. | β | 2018 | β |
| Reduction in endogenous cardiac steroids protects the brain from oxidative stress in a mouse model of mania induced by amphetamine. | Hodes A et al. | β | 2018 | β |
| Alcohol use and bipolar disorders: Risk factors associated with their co-occurrence and sequence of onsets. | Azorin JM et al. | β | 2017 | β |
| A model of the mitochondrial basis of bipolar disorder. | Morris G et al. | β | 2017 | β |
| Animal models for bipolar disorder: from bedside to the cage. | Beyer DKE et al. | β | 2017 | β |
| An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms. | Won E et al. | β | 2017 | β |
| Antidepressant-induced Dopamine Receptor Dysregulation: A Valid Animal Model of Manic-Depressive Illness. | Demontis F et al. | β | 2017 | β |
| Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia. | Liu YN et al. | β | 2017 | β |
| Biological hypotheses and biomarkers of bipolar disorder. | Sigitova E et al. | β | 2017 | β |
| Different patterns of dopaminergic and serotonergic dysfunction in manic, depressive and euthymic phases of bipolar disorder. | Nikolaus S et al. | β | 2017 | β |
| Does the number of previous mood episodes moderate the relationship between alcohol use, smoking and mood in bipolar outpatients? | Ter Meulen WG et al. | β | 2017 | β |
| Dopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis. | Szmulewicz AG et al. | β | 2017 | β |
| Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies. | Davis MT et al. | β | 2017 | β |
| Reward processing and mood-related symptoms: An RDoC and translational neuroscience perspective. | Nusslock R et al. | β | 2017 | β |
| Stressful life events and catechol-O-methyl-transferase (COMT) gene in bipolar disorder. | Hosang GM et al. | β | 2017 | β |
| The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorder. | Miskowiak KW et al. | β | 2017 | β |
| The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment. | Ashok AH et al. | β | 2017 | β |
| Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression. | Ricken R et al. | β | 2017 | β |
| Anticonvulsant medications attenuate amphetamine-induced deficits in behavioral inhibition but not decision making under risk on a rat gambling task. | Tremblay M et al. | β | 2016 | β |
| Attention-deficit hyperactivity disorder, its pharmacotherapy, and the risk of developing bipolar disorder: A nationwide population-based study in Taiwan. | Wang LJ et al. | β | 2016 | β |
| Bipolar disorder, a precursor of Parkinson's disease? | Novaretti TMS et al. | β | 2016 | β |
| Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. | Henriksen TE et al. | β | 2016 | β |
| Circadian clock gene aryl hydrocarbon receptor nuclear translocator-like polymorphisms are associated with seasonal affective disorder: An Indian family study. | Rajendran B et al. | β | 2016 | β |
| Circadian preferences, oxidative stress and inflammatory cytokines in bipolar disorder: A community study. | Mondin TC et al. | β | 2016 | β |
| Drugs related to monoamine oxidase activity. | FiΕ‘ar Z | β | 2016 | β |
| Effects of Neonatal Dexamethasone Exposure on Adult Neuropsychiatric Traits in Rats. | Yates NJ et al. | β | 2016 | β |
| Interaction between COMT rs5993883 and second generation antipsychotics is linked to decreases in verbal cognition and cognitive control in bipolar disorder. | Flowers SA et al. | β | 2016 | β |
| Modeling mania in preclinical settings: A comprehensive review. | Sharma AN et al. | β | 2016 | β |
| Nod-like receptor pyrin containing 3 (NLRP3) in the post-mortem frontal cortex from patients with bipolar disorder: A potential mediator between mitochondria and immune-activation. | Kim HK et al. | β | 2016 | β |
| Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches. | Balmus IM et al. | β | 2016 | β |
| Regulators of mitochondrial complex I activity: A review of literature and evaluation in postmortem prefrontal cortex from patients with bipolar disorder. | Duong A et al. | β | 2016 | β |
| Relationship between ST8SIA2, polysialic acid and its binding molecules, and psychiatric disorders. | Sato C et al. | β | 2016 | β |
| The known and missing links between Toxoplasma gondii and schizophrenia. | Elsheikha HM et al. | β | 2016 | β |
| The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases. | Morris G et al. | β | 2016 | β |
| When the party is over: depressive-like states in rats following termination of cortical D1 receptor overexpression. | Freund N et al. | β | 2016 | β |
| Amphetamine sensitization in mice is sufficient to produce both manic- and depressive-related behaviors as well as changes in the functional connectivity of corticolimbic structures. | Pathak G et al. | β | 2015 | β |
| Antimanic-like activity of candesartan in mice: Possible involvement of antioxidant, anti-inflammatory and neurotrophic mechanisms. | de Souza Gomes JA et al. | β | 2015 | β |
| A Positive Affective Neuroendocrinology Approach to Reward and Behavioral Dysregulation. | Welker KM et al. | β | 2015 | β |
| A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates. | Brand SJ et al. | β | 2015 | β |
| Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. | Sutterland AL et al. | β | 2015 | β |
| Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor Ξ²-arrestin interactions. | Gao Y et al. | β | 2015 | β |
| Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review. | Deepmala et al. | β | 2015 | β |
| Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. | Mertens J et al. | β | 2015 | β |
| Dopamine transporter gene may be associated with bipolar disorder and its personality traits. | Huang CC et al. | β | 2015 | β |
| Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder. | Dodd S et al. | β | 2015 | β |
| GBR 12909 administration as an animal model of bipolar mania: time course of behavioral, brain oxidative alterations and effect of mood stabilizing drugs. | Queiroz AI et al. | β | 2015 | β |
| Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies. | van Enkhuizen J et al. | β | 2015 | β |
| Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology. | Parrott JM et al. | β | 2015 | β |
| The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited. | van Enkhuizen J et al. | β | 2015 | β |
| The development and course of bipolar spectrum disorders: an integrated reward and circadian rhythm dysregulation model. | Alloy LB et al. | β | 2015 | β |
| The Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar Disorder. | Kim HK et al. | β | 2015 | β |
| The Relationship between Serum Vitamin D Level and Attention Deficit Hyperactivity Disorder. | Sharif MR et al. | β | 2015 | β |
| The role of encoding strategies in contextual memory deficits in patients with bipolar disorder. | CorrΓͺa MS et al. | β | 2015 | β |
| Valuing happiness is associated with bipolar disorder. | Ford BQ et al. | β | 2015 | β |
| Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis. | Kishi T et al. | β | 2015 | β |
| A highly tunable dopaminergic oscillator generates ultradian rhythms of behavioral arousal. | Blum ID et al. | β | 2014 | β |
| Allostasis as a conceptual framework linking bipolar disorder and addiction. | Pettorruso M et al. | β | 2014 | β |
| Altered resting-state functional connectivity of striatal-thalamic circuit in bipolar disorder. | Teng S et al. | β | 2014 | β |
| Analysis of the presence or absence of atrophy of the subgenual and subcallosal cingulate cortices using voxel-based morphometry on MRI is useful to select prescriptions for patients with depressive symptoms. | Niida A et al. | β | 2014 | β |
| A systems neuroscience perspective of schizophrenia and bipolar disorder. | Frangou S | β | 2014 | β |
| Can Antipsychotic Agents be Considered as Real Antimanic Treatments? | Bourin M et al. | β | 2014 | β |
| Elevated reward-related neural activation as a unique biological marker of bipolar disorder: assessment and treatment implications. | Nusslock R et al. | β | 2014 | β |
| Evaluation of the antidepressant, anxiolytic and memory-improving efficacy of aripiprazole and fluoxetine in ethanol-treated rats. | Burda-Malarz K et al. | β | 2014 | β |
| Functional and structural alterations in the cingulate motor area relate to decreased fronto-striatal coupling in major depressive disorder with psychomotor disturbances. | Liberg B et al. | β | 2014 | β |
| Integrated neurobiology of bipolar disorder. | Maletic V et al. | β | 2014 | β |
| Medicinal chemistry of catechol O-methyltransferase (COMT) inhibitors and their therapeutic utility. | Kiss LE et al. | β | 2014 | β |
| Memantine: New prospective in bipolar disorder treatment. | Serra G et al. | β | 2014 | β |
| "Messing with the mind": evolutionary challenges to human brain augmentation. | Saniotis A et al. | β | 2014 | β |
| Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia. | Kim HK et al. | β | 2014 | β |
| The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment. | de Bartolomeis A et al. | β | 2014 | β |
| The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment. | Andreazza AC et al. | β | 2014 | β |
| Classification of bipolar disorder using basal-ganglia-related functional connectivity in the resting state. | Teng S et al. | β | 2013 | β |
| Delirious mania: detection, diagnosis, and clinical management in the acute setting. | Jacobowski NL et al. | β | 2013 | β |
| Effects of lithium on oxidative stress and behavioral alterations induced by lisdexamfetamine dimesylate: relevance as an animal model of mania. | MacΓͺdo DS et al. | β | 2013 | β |
| Effects of sodium butyrate in animal models of mania and depression: implications as a new mood stabilizer. | Resende WR et al. | β | 2013 | β |
| Evaluation of acetylcholinesterase in an animal model of mania induced by D-amphetamine. | Varela RB et al. | β | 2013 | β |
| How assess drugs in the treatment of acute bipolar mania? | Bourin M et al. | β | 2013 | β |
| Novel nutritional treatment for manic and psychotic disorders: a review of tryptophan and tyrosine depletion studies and the potential of protein-based formulations using glycomacropeptide. | Badawy A | β | 2013 | β |
| Pathway analysis using information from allele-specific gene methylation in genome-wide association studies for bipolar disorder. | Chuang LC et al. | β | 2013 | β |
| Potential mechanisms of action of lithium in bipolar disorder. Current understanding. | Malhi GS et al. | β | 2013 | β |
| Reduced hedonic capacity in euthymic bipolar subjects: a trait-like feature? | Di Nicola M et al. | β | 2013 | β |
| Sodium butyrate reverses the inhibition of Krebs cycle enzymes induced by amphetamine in the rat brain. | Valvassori SS et al. | β | 2013 | β |
| Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. | Andreazza AC et al. | β | 2013 | β |
| The role of estrogen in the treatment of men with schizophrenia. | Kulkarni J et al. | β | 2013 | β |
| The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence. | Nunes SO et al. | β | 2013 | β |
| Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour? | Webster JP et al. | β | 2013 | β |
| Antipsychotics in the treatment of bipolar disorder. | Singh J et al. | β | 2012 | β |
| Association of CLOCK gene variants with semen quality in idiopathic infertile Han-Chinese males. | Zhang J et al. | β | 2012 | β |
| Better than I thought: positive evaluation bias in hypomania. | Mason L et al. | β | 2012 | β |
| Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders. | Andreazza AC | β | 2012 | β |
| Dietary selenium and major depression: a nested case-control study. | Pasco JA et al. | β | 2012 | β |
| Effects of alpha-lipoic acid in an animal model of mania induced by D-amphetamine. | MacΓͺdo DS et al. | β | 2012 | β |
| Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans. | Basselin M et al. | β | 2012 | β |
| Neural activations during auditory oddball processing discriminating schizophrenia and psychotic bipolar disorder. | Ethridge LE et al. | β | 2012 | β |
| Overlapping prefrontal systems involved in cognitive and emotional processing in euthymic bipolar disorder and following sleep deprivation: a review of functional neuroimaging studies. | McKenna BS et al. | β | 2012 | β |
| Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study. | MagalhΓ£es PV et al. | β | 2012 | β |
| Psychiatric disorders in ageing. | Wijeratne C et al. | β | 2012 | β |
| The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. | Bond DJ et al. | β | 2012 | β |
| The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence. | Sani G et al. | β | 2012 | β |
| The role of parasites and pathogens in influencing generalised anxiety and predation-related fear in the mammalian central nervous system. | Kaushik M et al. | β | 2012 | β |
| Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literature. | Chopra A et al. | β | 2012 | β |
| Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia. | Hope S et al. | β | 2011 | β |
| A manic episode in a 64-year-old man: an adverse effect of varenicline. | Ahmed AI | β | 2011 | β |
| Bizarreness in dream reports and waking fantasies of psychotic schizophrenic and manic patients: empirical evidences and theoretical consequences. | Limosani I et al. | β | 2011 | β |
| Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats. | Ramadan E et al. | β | 2011 | β |
| Cognitive manic symptoms associated with the P2RX7 gene in bipolar disorder. | Backlund L et al. | β | 2011 | β |
| Downregulation and upregulation of glial connexins may cause synaptic imbalances responsible for the pathophysiology of bipolar disorder. | Mitterauer BJ | β | 2011 | β |
| Elevation of cerebrospinal fluid interleukin-1Γ in bipolar disorder. | SΓΆderlund J et al. | β | 2011 | β |
| Evaluation of basal ganglia, brainstem raphe and ventricles in bipolar disorder by transcranial sonography. | Krogias C et al. | β | 2011 | β |
| Evidence for somatic gene conversion and deletion in bipolar disorder, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, type-1 diabetes, and type-2 diabetes. | Ross KA | β | 2011 | β |
| fMRI evidence of a relationship between hypomania and both increased goal-sensitivity and positive outcome-expectancy bias. | O'Sullivan N et al. | β | 2011 | β |
| Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats. | Burda K et al. | β | 2011 | β |
| Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. | Berk M et al. | β | 2011 | β |
| SIRT1 gene, schizophrenia and bipolar disorder in the Japanese population: an association study. | Kishi T et al. | β | 2011 | β |
| Sleep disturbance as transdiagnostic: consideration of neurobiological mechanisms. | Harvey AG et al. | β | 2011 | β |
| A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder. | Dodd S et al. | β | 2010 | β |
| Assessing oxidative pathway genes as risk factors for bipolar disorder. | Fullerton JM et al. | β | 2010 | β |
| Association study between a polymorphism at the 3'-untranslated region of CLOCK gene and attention deficit hyperactivity disorder. | Xu X et al. | β | 2010 | β |
| Circadian rhythms and sleep in bipolar disorder. | Murray G et al. | β | 2010 | β |
| Cross-species assessments of motor and exploratory behavior related to bipolar disorder. | Henry BL et al. | β | 2010 | β |
| Delineating the psychic structure of substance abuse and addictions: should anxiety, mood and impulse-control dysregulation be included? | Pani PP et al. | β | 2010 | β |
| Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. | Valvassori SS et al. | β | 2010 | β |
| Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder. | Olsson SK et al. | β | 2010 | β |
| Higher striatal dopamine transporters in euthymic patients with bipolar disorder: a SPECT study with [Tc] TRODAT-1. | Chang TT et al. | β | 2010 | β |
| Lack of association between MAGEL2 and schizophrenia and mood disorders in the Japanese population. | Fukuo Y et al. | β | 2010 | β |
| Low frequency of bipolar disorder, dopamine dysregulation syndrome, and punding in Brazilian patients with Parkinson's disease. | Kummer A et al. | β | 2010 | β |
| Midline brain abnormalities in established bipolar affective disorder. | Takahashi T et al. | β | 2010 | β |
| Modeling complex genetic and environmental influences on comorbid bipolar disorder with tobacco use disorder. | McEachin RC et al. | β | 2010 | β |
| Switching to hypomania and mania: differential neurochemical, neuropsychological, and pharmacologic triggers and their mechanisms. | Chen J et al. | β | 2010 | β |
| The clinical significance of creativity in bipolar disorder. | Murray G et al. | β | 2010 | β |
| 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. | Andreazza AC et al. | β | 2009 | β |
| Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population. | Kishi T et al. | β | 2009 | β |
| Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice. | Bourin M et al. | β | 2009 | β |
| Bipolar disorder and dopamine dysfunction: an indirect approach focusing on tardive movement syndromes in a naturalistic setting. | van Rossum I et al. | β | 2009 | β |
| Circadian polymorphisms associated with affective disorders. | Kripke DF et al. | β | 2009 | β |
| Dissociable brain structural changes associated with predisposition, resilience, and disease expression in bipolar disorder. | Kempton MJ et al. | β | 2009 | β |
| Electrophysiological correlates of sleep disturbance induced by acute and chronic administration of D-amphetamine. | Andersen ML et al. | β | 2009 | β |
| Increased serum neurotrophin-4/5 levels in bipolar disorder. | Walz JC et al. | β | 2009 | β |
| Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD. | RydΓ©n E et al. | β | 2009 | β |
| Persistent genital arousal disorder (PGAD): case report of long-term symptomatic management with electroconvulsive therapy. | Korda JB et al. | β | 2009 | β |
| The role of dopamine in bipolar disorder. | Cousins DA et al. | β | 2009 | β |
| The role of lithium in modulation of brain genes: relevance for aetiology and treatment of bipolar disorder. | Fatemi SH et al. | β | 2009 | β |
| Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain. | Basselin M et al. | β | 2008 | β |
| Dopamine and bipolar disorder. | Kummer A et al. | β | 2008 | β |
| Euthymic patients with bipolar disorder show decreased reward learning in a probabilistic reward task. | Pizzagalli DA et al. | β | 2008 | β |
| Glutathione: a novel treatment target in psychiatry. | Berk M et al. | β | 2008 | β |
| Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania. | Berk M et al. | β | 2008 | β |
| Is co-administration of bupropion with SSRIs and SNRIs in forced swimming test in mice, predictive of efficacy in resistant depression? | Prica C et al. | β | 2008 | β |
| Olanzapine/fluoxetine combination for treatment-resistant depression: efficacy and clinical utility. | Dodd S et al. | β | 2008 | β |
| Oxidative stress markers in bipolar disorder: a meta-analysis. | Andreazza AC et al. | β | 2008 | β |
| Mania matters! | Malhi GS et al. | β | 2007 | β |